IN2012DN03358A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN03358A IN2012DN03358A IN3358DEN2012A IN2012DN03358A IN 2012DN03358 A IN2012DN03358 A IN 2012DN03358A IN 3358DEN2012 A IN3358DEN2012 A IN 3358DEN2012A IN 2012DN03358 A IN2012DN03358 A IN 2012DN03358A
- Authority
- IN
- India
- Prior art keywords
- relates
- compositions
- improving
- processes
- production
- Prior art date
Links
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000014616 translation Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25952709P | 2009-11-09 | 2009-11-09 | |
US12/941,347 US8524458B2 (en) | 2009-11-09 | 2010-11-08 | Secretory protein biomarkers for high efficiency protein expression |
PCT/US2010/055953 WO2011057239A2 (fr) | 2009-11-09 | 2010-11-09 | Biomarqueurs de protéines sécrétoires pour une expression à haute efficacité des protéines |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN03358A true IN2012DN03358A (fr) | 2015-10-23 |
Family
ID=43431809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3358DEN2012 IN2012DN03358A (fr) | 2009-11-09 | 2010-11-09 |
Country Status (14)
Country | Link |
---|---|
US (2) | US8524458B2 (fr) |
EP (1) | EP2499254A2 (fr) |
JP (1) | JP2013510324A (fr) |
KR (1) | KR20120115494A (fr) |
CN (1) | CN102666873A (fr) |
AU (1) | AU2010314922A1 (fr) |
BR (1) | BR112012010976A2 (fr) |
CA (1) | CA2778254A1 (fr) |
IL (1) | IL219518A0 (fr) |
IN (1) | IN2012DN03358A (fr) |
MX (1) | MX2012005380A (fr) |
RU (1) | RU2012124114A (fr) |
WO (1) | WO2011057239A2 (fr) |
ZA (1) | ZA201202966B (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6507542B2 (ja) * | 2014-09-22 | 2019-05-08 | 東洋紡株式会社 | バイオマーカーを用いた組換えタンパク質生産量の予測方法 |
EP3255054A1 (fr) * | 2016-06-06 | 2017-12-13 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Procédé pour la purification de complexes macromoléculaires biologiques |
CN108467890A (zh) * | 2018-05-02 | 2018-08-31 | 首都医科大学附属北京天坛医院 | Vat1基因及vat1基因的干扰物的应用和应用vat1基因的产品 |
CN109470756B (zh) * | 2018-10-11 | 2020-08-25 | 昆明理工大学 | 测定14-3-3蛋白与质膜H+-ATPase蛋白互作的电化学方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
US5302517A (en) * | 1987-06-16 | 1994-04-12 | The Board Of Regents Of The University Of Nebraska | Method of controlling the expression of a gene in a cell culture, cell culture vector used in the method and method of making the vector |
AU632065B2 (en) | 1988-09-23 | 1992-12-17 | Novartis Vaccines And Diagnostics, Inc. | Cell culture medium for enhanced cell growth, culture longevity and product expression |
US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
US20050272055A1 (en) * | 2000-02-01 | 2005-12-08 | Rina Das | Method of treating lethal shock induced by toxic agents and diagnosing exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes |
JP2009534036A (ja) * | 2006-04-21 | 2009-09-24 | ワイス | 細胞培養表現型の示差的発現プロファイリング分析およびその使用 |
US8242057B2 (en) * | 2006-06-26 | 2012-08-14 | Cleveland Biolabs, Inc. | Methods for identifying modulators of apoptosis |
WO2009146915A2 (fr) * | 2008-06-04 | 2009-12-10 | Proteosys Ag | Biomarqueurs protéiques pour l'expérimentation in vitro des toxicité et embryotoxicité développementales de substances chimiques |
-
2010
- 2010-11-08 US US12/941,347 patent/US8524458B2/en not_active Expired - Fee Related
- 2010-11-09 CA CA2778254A patent/CA2778254A1/fr not_active Abandoned
- 2010-11-09 JP JP2012538076A patent/JP2013510324A/ja active Pending
- 2010-11-09 KR KR1020127014730A patent/KR20120115494A/ko not_active Application Discontinuation
- 2010-11-09 AU AU2010314922A patent/AU2010314922A1/en not_active Abandoned
- 2010-11-09 WO PCT/US2010/055953 patent/WO2011057239A2/fr active Application Filing
- 2010-11-09 CN CN2010800503369A patent/CN102666873A/zh active Pending
- 2010-11-09 EP EP10778803A patent/EP2499254A2/fr not_active Withdrawn
- 2010-11-09 BR BR112012010976A patent/BR112012010976A2/pt not_active IP Right Cessation
- 2010-11-09 IN IN3358DEN2012 patent/IN2012DN03358A/en unknown
- 2010-11-09 MX MX2012005380A patent/MX2012005380A/es not_active Application Discontinuation
- 2010-11-09 RU RU2012124114/10A patent/RU2012124114A/ru not_active Application Discontinuation
-
2012
- 2012-04-23 ZA ZA2012/02966A patent/ZA201202966B/en unknown
- 2012-05-01 IL IL219518A patent/IL219518A0/en unknown
-
2013
- 2013-08-30 US US14/016,035 patent/US20140004531A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20140004531A1 (en) | 2014-01-02 |
KR20120115494A (ko) | 2012-10-18 |
EP2499254A2 (fr) | 2012-09-19 |
WO2011057239A2 (fr) | 2011-05-12 |
CN102666873A (zh) | 2012-09-12 |
CA2778254A1 (fr) | 2011-05-12 |
IL219518A0 (en) | 2012-06-28 |
AU2010314922A1 (en) | 2012-05-31 |
ZA201202966B (en) | 2012-12-27 |
US8524458B2 (en) | 2013-09-03 |
MX2012005380A (es) | 2012-05-29 |
BR112012010976A2 (pt) | 2016-08-16 |
US20110236906A1 (en) | 2011-09-29 |
RU2012124114A (ru) | 2013-12-20 |
WO2011057239A3 (fr) | 2011-06-30 |
JP2013510324A (ja) | 2013-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019500694A1 (en) | Factor viii compositions and methods of making and using the same | |
EP2470559A4 (fr) | Compositions de facteur ix de coagulation et leurs procédés de fabrication et d'utilisation | |
IN2012DN06277A (fr) | ||
IN2014CN02100A (fr) | ||
MX2013003681A (es) | Ácidos nucleicos manipulados y métodos de uso de los mismos. | |
IN2012DN03825A (fr) | ||
WO2014035475A8 (fr) | Procédés de contrôle de l'hétérogénéité des protéines | |
WO2011123830A3 (fr) | Compositions d'alpha 1-antitrypsine, leurs procédés de préparation et d'utilisation | |
EA201190326A8 (ru) | Полипептиды гормона роста и способы их получения и применения | |
MX2014001383A (es) | Colageno 7 y metodos relacionados. | |
WO2013040093A3 (fr) | Compositions de peptide-2 de type glucagon et leurs procédés de fabrication et d'utilisation | |
AU2012257942A8 (en) | Amino acid sequences directed against IL-17A, IL-17F and/or IL17-A/F and polypeptides comprising the same | |
MX346700B (es) | Metodo para mejorar el rendimiento de un polipeptido. | |
PH12014501912A1 (en) | Cx3cr1-binding polypeptides | |
EA201290565A1 (ru) | Получение белка гемагглютинин-нейраминидазы в микроводорослях | |
MX2016008258A (es) | Celulas eucariotas novedosas y metodos para la expresion recombinante de un producto de interes. | |
WO2012136898A3 (fr) | Nouvelles cutinases, leur préparation et leurs utilisations | |
MY180183A (en) | Methods and compositions for preventing norleucine misincorporation into proteins | |
MX2011012623A (es) | Construcciones de casb7439. | |
IN2012DN03358A (fr) | ||
WO2013063528A3 (fr) | Variants d'isoprène synthase ayant une solubilité améliorée pour la production d'isoprène | |
NZ709120A (en) | Beta-hexosyl-transferases and uses thereof | |
WO2010108182A3 (fr) | Production de protéines de recombinaison dans des ciliés et leurs utilisations | |
WO2012175745A9 (fr) | Protéines secrétées par une cellule pour le traitement d'un infarctus du myocarde | |
WO2012129449A3 (fr) | Production à haut niveau de protéines recombinantes |